Tempus AI

Tempus AI Days Inventory Outstanding

The Days Inventory Outstanding (DIO) of Tempus AI (TEM) as of Nov 20, 2026 is 39.84. In the previous year, Days Inventory Outstanding (DIO) was 44.87 — a change of -11.20% (lower).

Days Inventory Outstanding

39.84

YoY

-11.20%

Last updated:

Days Inventory Outstanding (DIO) of Tempus AI is 2025 39.84 . Days Inventory Outstanding (DIO) of Tempus AI was 2024 44.87 . It decreases by -11.20% lower compared to the previous year.

The Tempus AI Days Inventory Outstanding history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Days Inventory Outstanding
Date
Days Inventory Outstanding
Jan 1, 2019
65.67 USD
Jan 1, 2020
86.06 USD
Jan 1, 2021
48.00 USD
Jan 1, 2022
42.70 USD
Jan 1, 2023
42.86 USD
Jan 1, 2024
44.87 USD
Jan 1, 2025
39.84 USD
The Tempus AI Days Inventory Outstanding history
YEARDays Inventory OutstandingYoY
39.84-11.20%
44.87+4.68%
42.86+0.38%
42.70-11.04%
48.00-44.23%
86.06+31.05%
65.67—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Tempus AI Stock analysis

What does Tempus AI do? Tempus AI Inc provides next generation diagnostics through genomics, data, and AI applications. Its genomics product line includes next generation sequencing, diagnostics, PCR, profiling, molecular genotyping, and pathology testing. The AI applications focus on algorithmic diagnostics, software as a medical device, and clinical decision support tools. The primary AI product Next uses machine learning to identify care gaps for oncology and cardiology patients. The company serves healthcare providers and life sciences organizations seeking personalized medicine solutions. Tempus AI Inc's revenue comes from its genomics and AI product lines. The genomics services are delivered through its laboratories, offering sequencing, diagnostics, and molecular testing. The AI applications, particularly Next, are sold as software solutions to healthcare institutions. The target customers are healthcare providers and life sciences companies that require advanced diagnostic tools for personalized treatment plans. The company operates in the Life Sciences Tools & Services industry, focusing on oncology and cardiology segments. The company's genomics product line generates revenue through laboratory services for molecular pathology testing. AI applications like Next are sold as medical device software, targeting healthcare institutions for clinical decision support. The primary segments served are oncology and cardiology, where personalized medicine is critical. The company's products are designed to integrate with existing healthcare data systems to improve patient care outcomes. Tempus AI is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Tempus AI stock

Days Inventory Outstanding (DIO) of Tempus AI is 39.84 in 2025.

Days Inventory Outstanding (DIO) of Tempus AI changed from 44.87 to 39.84, representing a -11.20% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Days Inventory Outstanding (DIO) Tempus AI since 2006 – with annual values, charts, and detailed analysis.

DIO measures the average number of days inventory is held before being sold. Lower values indicate more efficient inventory management.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Days Inventory Outstanding (DIO)'s Tempus AI with sector peers and the industry average to assess whether it is attractive.

To evaluate Days Inventory Outstanding (DIO)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Days Inventory Outstanding (DIO).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Profitability — Tempus AI

All Key Metrics — Tempus AI